2022
DOI: 10.1016/j.ijpharm.2022.121958
|View full text |Cite
|
Sign up to set email alerts
|

Controlling drug release by introducing lipase inhibitor within a lipid formulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0
4

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 38 publications
0
2
0
4
Order By: Relevance
“…As PBA at the concentration of >100 μM has been shown to inhibit more than 60% of lipase activity, 41 the result strongly suggests the role of lipase in macrophagemediated PTMC erosion. In addition, orlistat (also known as tetrahydrolipstatin), a potent drug that inhibits the catalytic activity of lipase in monocyte cell-derived macrophages, 42,43 also demonstrated a similar dose-related suppression on PTMC erosion in the macrophages' incubation (Figure 8C,F). Therefore, several potential factors to the biodegradation of PTMC raised to date were detected at the cellular level.…”
Section: Factors Secreted By Macrophages In Eroding Ptmcmentioning
confidence: 80%
“…As PBA at the concentration of >100 μM has been shown to inhibit more than 60% of lipase activity, 41 the result strongly suggests the role of lipase in macrophagemediated PTMC erosion. In addition, orlistat (also known as tetrahydrolipstatin), a potent drug that inhibits the catalytic activity of lipase in monocyte cell-derived macrophages, 42,43 also demonstrated a similar dose-related suppression on PTMC erosion in the macrophages' incubation (Figure 8C,F). Therefore, several potential factors to the biodegradation of PTMC raised to date were detected at the cellular level.…”
Section: Factors Secreted By Macrophages In Eroding Ptmcmentioning
confidence: 80%
“…It is logical to assume that such formulations, delivering the drug in its lipid-based carrier, are preferred to increase bioavailability. However, when the lipid formulation undergoes enzymatic degradation, drug precipitation may occur, resulting in a negligible effect on drug absorption [22,23]. Enzymatic degradation might be due to colonic fermentation as well.…”
Section: Oral Route 21 In Vitro Methodsmentioning
confidence: 99%
“…As lipases são essenciais para a digestão de gorduras e a inibição dessas enzimas pelo Orlistate pode levar a alterações gastrointestinais. Este mecanismo mostra que a supressão da atividade lipásica pode causar desequilíbrios na digestão de gorduras, potencialmente contribuindo para a inflamação (Murshed et al, 2022).…”
Section: Mediadores Envolvidosunclassified
“…Esta dose é geralmente considerada um equilíbrio ideal entre eficácia e tolerabilidade. Entretanto, há uma variação significativa na resposta individual, o que pode afetar a incidência de inflamação gastrointestinal (Candela et al 2021) (Murshed et al, 2022).…”
Section: Efeitos Em Diferentes Dosesunclassified